Speaker illustration

Miss Maria Lodi

University of Debrecen, Debrecen (Hungary)

Advantages of prophylactic versus conventionally scheduled heart failure treatment in doxorubicin induced cardiomyopathy

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiac Diseases

Session: Basic Science - Cardiac Diseases

Thumbnail

Early, combined heart failure therapy attenuates doxorubicin cardiomyopathy in rats

Event: ESC CONGRESS 2017

Topic: Cardiotoxicity of drugs

Session: Chronic heart failure (CHF)

Thumbnail

Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Animal models and experimentation

Session: Rapid Fire 1 - Basic Science

Thumbnail

This platform is supported by

logo Novo Nordisk